From Wall Street to Tokyo, from Berlin to the Nordics — every month, Sales Magazine breaks down the markets driving global B2B growth.
USA · Japan · China · Canada · Germany · Austria · Switzerland · Luxembourg · Belgium · Netherlands · Sweden · Norway · Finland · Denmark
One email per month. You can unsubscribe at any time.
Statistics Denmark's September data release confirms 2% GDP growth for 2026, with the pharmaceutical sector still dominant but household consumption and business investment both contributing meaningfully for the first time this cycle.
Nordea's September 2026 outlook finds Denmark's growth continuing at a solid pace as the recovery broadens beyond pharmaceuticals — public finance pressure and narrowing current account surplus are the watch points.
Danske Bank's September Nordic Outlook sees Denmark's high growth rate continuing — but highlights that the domestic economy is steadier than the headline numbers suggest, with growth concentrating in specific segments.
Denmark's recovery is starting to feel real to ordinary households — not just in the GDP statistics. Does the latest industrial signal mark the beginning of a durable recovery, or only a temporary improvement in a divided market? Beyond the headline figures, the underlying changes may influence customer confidence, budget approvals, investment timing, and the arguments buyers expect from potential suppliers. Understanding those connections can help international sales professionals distinguish a promising market signal from short-lived statistical noise. We look at what the shift could mean for suppliers, exporters, and sales teams targeting investment-led demand. Read on for a source-based overview of the latest developments, their wider business context, and the questions companies should consider when planning their next commercial move.
The OECD is bullish on Denmark — with one significant caveat about what happens if the GLP-1 boom stalls. How will changing inflation and interest-rate expectations influence investment, purchasing decisions, and sales cycles? Beyond the headline figures, the underlying changes may influence customer confidence, budget approvals, investment timing, and the arguments buyers expect from potential suppliers. Understanding those connections can help international sales professionals distinguish a promising market signal from short-lived statistical noise. This article examines the signals commercial teams should watch as financing conditions reshape buyer priorities. Read on for a source-based overview of the latest developments, their wider business context, and the questions companies should consider when planning their next commercial move.
Denmark is the Nordic outperformer of 2026 — and Novo Nordisk is not the only reason. How will changing inflation and interest-rate expectations influence investment, purchasing decisions, and sales cycles? Beyond the headline figures, the underlying changes may influence customer confidence, budget approvals, investment timing, and the arguments buyers expect from potential suppliers. Understanding those connections can help international sales professionals distinguish a promising market signal from short-lived statistical noise. This article examines the signals commercial teams should watch as financing conditions reshape buyer priorities. Read on for a source-based overview of the latest developments, their wider business context, and the questions companies should consider when planning their next commercial move.
